- Datum24.02.2025
- Uhrzeit08:00 - 09:00 Uhr
- Veranstalter
XTB
Kein Moderator verfügbar
Merck KGaA Nam.-Akt.(Sp.ADRs) 1/5/o.N. Aktie
Verkaufen
Kaufen
Merck KGaA Nam.-Akt.(Sp.ADRs) 1/5/o.N. Chart
Merck KGaA Nam.-Akt.(Sp.ADRs) 1/5/o.N. Realtime-Kurs
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| Stuttgart | VK | |||||
| Baader | VK | |||||
| Quotrix | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Stuttgart)
-1,48 %
Intraday
-0,75 %
1 Woche
-6,99 %
1 Monat
-2,92 %
Seit Jahresbeginn
-15,29 %
1 Jahr
-23,56 %
3 Jahre
8,13 %
5 Jahre
Wikifolio
Passender Service zu Merck KGaA Nam.-Akt.(Sp.ADRs) 1/5/o.N.
Webinar zu Merck KGaA Nam.-Akt.(Sp.ADRs) 1/5/o.N.
Kursinformationen (Stuttgart)
- Tagestief / Hoch (€)-
- 52W-Tief / Hoch (€)20,600-35,000
- Jahrestief / Hoch (€)26,000-30,400
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Merck KGaA Nam.-Akt.(Sp.ADRs) 1/5/o.N.
| Ex-Datum | Fiskaljahr | Dividende | Rendite |
|---|---|---|---|
| - | 2027 (e) | ||
| - | 2026 (e) | ||
| - | 2025 (e) | ||
| - | 2024 (e) | ||
| 29.04.2024 | 2023 | 0,470654 $ | 1,48 % |
| 02.05.2023 | 2022 | 0,485381 $ | 1,38 % |
| 25.04.2022 | 2021 | 0,391645 $ | 1,05 % |
| 26.04.2021 | 2020 | 0,339234 $ | 0,99 % |
| 01.06.2020 | 2019 | 0,291358 $ | 1,27 % |
| 29.04.2019 | 2018 | 0,280885 $ | 1,33 % |
| 01.05.2018 | 2017 | 0,299412 $ | 1,53 % |
Termine von Merck KGaA Nam.-Akt.(Sp.ADRs) 1/5/o.N.
Keine aktuellen Termine
Beschreibung
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
